Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Merck
Cantor Fitzgerald
Federal Trade Commission
Baxter
Teva

Generated: July 22, 2019

DrugPatentWatch Database Preview

Patent: 7,329,642

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,329,642
Title:.beta.-2-glycoprotein is an inhibitor of angiogenesis
Abstract: The present disclosure provides a method of inhibiting angiogenesis within a tissue of interest by providing either intact or nicked .beta.2-Glycoprotein 1 (.beta.2GP1) to cells associated with the tissue. The presence of .beta.2GP1 inhibits angiogenesis within the tissue, in part by preventing neovascularization into the tissue. The disclosure also provides a method for treating tumors by providing .beta.2GP1 to the tumor.
Inventor(s): Schroit; Alan Jay (Bellaire, TX), Balasubramanian; Krishnakumar (Pearland, TX), McCarty; Marya (Houston, TX)
Assignee: Board of Regents, University of Texas System (Austin, TX)
Application Number:10/406,158
Patent Claims:see list of patent claims

Details for Patent 7,329,642

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Try a Free Trial Board of Regents, University of Texas System (Austin, TX) ➤ Try a Free Trial RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 7,329,642

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 03099833 Aug 26, 2004
World Intellectual Property Organization (WIPO) 03099833 Dec 04, 2003
United States of America 2003219406 Nov 27, 2003
United States of America 2008131397 Jun 05, 2008
United States of America 2010226887 Sep 09, 2010
United States of America 7642234 Jan 05, 2010
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
UBS
Fish and Richardson
Covington
Boehringer Ingelheim
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.